Core Viewpoint - Intuitive Surgical, Inc. (NASDAQ:ISRG) is facing challenges due to high stock multiples despite good earnings, with hospital utilization being the most critical metric for the company [1] Group 1: Company Overview - Intuitive Surgical designs and manufactures robotic systems for minimally invasive surgical and diagnostic procedures [3] - The company maintains a de facto monopoly in soft tissue robotic surgery globally, becoming the standard of care in many surgical modalities [3] Group 2: Investment Insights - Polen Capital Management initiated a 2.25% position in Intuitive Surgical in Q4 2025, selling positions in Netflix and Workday [3] - The company has launched a next-generation platform expected to accelerate procedure and revenue growth for years [3] - Current results indicate business momentum and a reasonable valuation, considering the company's accelerating monopoly [3]

Polen Capital Management Llc released its "Polen Focus Growth Strategy" Q4 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, the Polen Focus Growth strategy delivered a -1.37% gross return, underperforming the Russell 1000 Growth Index (+1.12%) and the S&P 500 (+2.66%), as concentrated mega‑cap leadership and AI valuation concerns drove market volatility. The fund faced headwinds from market rotation and valuation pressures but remained disciplined in its investment approach, fo ...